Related Articles
Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti‑cancer agents in the adjuvant setting
High postoperative carcinoembryonic antigen as an indicator of high‑risk stage II colon cancer
Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin‑based chemotherapy
Differences in carcinoembryonic antigen levels between colon and rectal cancer
Identification of high‑risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution